Blazar BR - Search Results

1

The IL-33/ST2 axis augments effector T-cell responses during acute GVHD.

Reichenbach DK, Schwarze V, Matta BM, Tkachev V, Lieberknecht E, Liu Q, Koehn BH, Pfeifer D, Taylor PA, Prinz G, Dierbach H, Stickel N, Beck Y, Warncke M, Junt T, Schmitt-Graeff A, Nakae S, Follo M, Wertheimer T, Schwab L, Devlin J, Watkins SC, Duyster J, Ferrara JL, Turnquist HR, Zeiser R, Blazar BR. Reichenbach DK, et al. Among authors: blazar br. Blood. 2015 May 14;125(20):3183-92. doi: 10.1182/blood-2014-10-606830. Epub 2015 Mar 26. Blood. 2015. PMID: 25814531 Free PMC article.

2

Promotion of murine marrow alloengraftment and hematopoietic recovery across the major histocompatibility barrier by administration of recombinant human interleukin-1 alpha.

Blazar BR, Widmer MB, Taylor PA, Vallera DA. Blazar BR, et al. Blood. 1992 Sep 15;80(6):1614-22. Blood. 1992. PMID: 1369829 Free article.

3

Effect of recombinant human macrophage colony-stimulating factor in irradiated murine recipients of T-cell-depleted allogeneic or non-depleted syngeneic bone marrow transplants.

Blazar BR, Aukerman SL, Vallera DA. Blazar BR, et al. Blood. 1992 Mar 15;79(6):1636-42. Blood. 1992. PMID: 1547353 Free article.

4

Prevention of murine graft-versus-host disease and bone marrow alloengraftment across the major histocompatibility barrier after donor graft preincubation with anti-LFA1 immunotoxin.

Blazar BR, Carroll SF, Vallera DA. Blazar BR, et al. Blood. 1991 Dec 1;78(11):3093-102. Blood. 1991. PMID: 1954395 Free article.

5

Pretreatment of murine donor grafts with L-leucyl-L-leucine methyl ester: elimination of graft-versus-host disease without detrimental effects on engraftment.

Blazar BR, Thiele DL, Vallera DA. Blazar BR, et al. Blood. 1990 Feb 1;75(3):798-805. Blood. 1990. PMID: 1967541 Free article.

6

Toxicity and efficacy of anti-T-cell ricin toxin A chain immunotoxins in a murine model of established graft-versus-host disease induced across the major histocompatibility barrier.

Vallera DA, Carroll SF, Snover DC, Carlson GJ, Blazar BR. Vallera DA, et al. Among authors: blazar br. Blood. 1991 Jan 1;77(1):182-94. Blood. 1991. PMID: 1984794 Free article.

7

Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome.

Weisdorf D, Haake R, Blazar B, Miller W, McGlave P, Ramsay N, Kersey J, Filipovich A. Weisdorf D, et al. Blood. 1990 Feb 15;75(4):1024-30. Blood. 1990. PMID: 2302454 Free article.

8

Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy.

Weisdorf DJ, Snover DC, Haake R, Miller WJ, McGlave PB, Blazar B, Ramsay NK, Kersey JH, Filipovich A. Weisdorf DJ, et al. Blood. 1990 Aug 1;76(3):624-9. Blood. 1990. PMID: 2378989 Free article.

9

Improved survival and leukocyte reconstitution without detrimental effects on engraftment in murine recipients of human recombinant granulocyte colony-stimulating factor after transplantation of T-cell-depleted histoincompatible bone marrow.

Blazar BR, Widmer MB, Cosman D, Sassenfeld HM, Vallera DA. Blazar BR, et al. Blood. 1989 Nov 1;74(6):2264-9. Blood. 1989. PMID: 2478225 Free article.

10

In vivo administration of recombinant human granulocyte/macrophage colony-stimulating factor in acute lymphoblastic leukemia patients receiving purged autografts.

Blazar BR, Kersey JH, McGlave PB, Vallera DA, Lasky LC, Haake RJ, Bostrom B, Weisdorf DR, Epstein C, Ramsay NK. Blazar BR, et al. Blood. 1989 Feb 15;73(3):849-57. Blood. 1989. PMID: 2644992 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

903 results

Search Page

Filters